We Have a New AbbVie Price Target After Our Previous One Was Reached - RealMoney
4/5/2022 12:00:00 AM3 years 1 month ago
by Bruce Kamich
by Bruce Kamich
We Have a New AbbVie (ABBV) Price Target After Our Previous One Was Reached...ABBV
AbbVie (ABBV) is a research-based biopharmaceutical company that was spun off from Abbott Laboratories (ABT) a number of years ago. Its blockbuster drug Humira brought in billions. We reviewed the c… [+2071 chars]
full article...